التفاصيل البيبلوغرافية
| العنوان: |
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer. |
| المؤلفون: |
Schoemaker, N E, Kuppens, I E L M, Moiseyenko, V, Glimelius, Bengt, Kjaer, M, Starkhammer, H, Richel, D J, Smaaland, R, Bertelsen, K, Poulsen, J P, Voznyi, E, Norum, J, Fennelly, D, Tveit, K M, Garin, A, Gruia, G, Mourier, A, Sibaud, D, Lefebvre, P, Beijnen, J H, Schellens, J H M, ten Bokkel Huinink, W W |
| المصدر: |
Br J Cancer. 91(8):1434-41 |
| مصطلحات موضوعية: |
Adenocarcinoma/*drug therapy/secondary, Adolescent, Adult, Aged, Antineoplastic Agents, Phytogenic/pharmacokinetics/*therapeutic use, Camptothecin/*analogs & derivatives/pharmacokinetics/*therapeutic use, Colorectal Neoplasms/*drug therapy/pathology, Comparative Study, DNA Topoisomerases, Type I/antagonists & inhibitors, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Research Support, Non-U.S. Gov't, Survival Rate, Treatment Outcome, MEDICINE, Surgery, Oncology, MEDICIN, Kirurgi, Onkologi |
| وصف الملف: |
print |
| الوصول الحر: |
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-70041Test
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15381932&dopt=CitationTest |
| قاعدة البيانات: |
SwePub |
